✦ LIBER ✦

Upfront Autologous Stem Cell Transplantation for Untreated High-Risk Diffuse Large B-Cell Lymphoma in Patients Up to 60 Years of Age

✍ Scribed by Takasaki, Hirotaka; Hashimoto, Chizuko; Fujita, Atsuko; Matsumoto, Kenji; Taguchi, Jun; Kuwabara, Hideyuki; Yamazaki, Etsuko; Koharazawa, Hideyuki; Fujita, Hiroyuki; Fujisawa, Shin; Ishii, Yoshimi; Yamamoto, Wataru; Motomura, Shigeki; Tomita, Naoto; Ishigatsubo, Yoshiaki; Sakai, Rika

Book ID: 125449009
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 216 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.03.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MCVAC regimen in autologous peripheral b

MCVAC regimen in autologous peripheral blood stem cell transplantation for high-risk diffuse large B cell lymphoma (DLBCL)

✍ J. Kato; K. Yokoyama; T. Mori; Y. Tsukada; C.-K. Chen; Y. Ikeda; S.-I. Okamoto 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Cell of origin fails to predict survival

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation

✍ Keni Gu; Dennis D Weisenburger; Kai Fu; Wing C Chan; Timothy C Greiner; Patricia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

New-Onset Lymphopenia Assessed during Ro

New-Onset Lymphopenia Assessed during Routine Follow-up Is a Risk Factor for Relapse Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma

✍ Luis F. Porrata; David J. Inwards; Stephen M. Ansell; Ivana N. Micallef; Patrick 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 308 KB

A phase II trial of rituximab as adjuvan

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

✍ Coso, D; Sebban, C; Boulat, O; Biron, P; Rey, J; Aurran, T; Chabannon, C; Xerri, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 145 KB

Impact of high-dose chemotherapy and aut

Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients: a single-center study in Japan

✍ Inano, Shojiro; Iwasaki, Makoto; Iwamoto, Yoshihiro; Sueki, Yuki; Fukunaga, Akik 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 250 KB

The non-relapse mortality rate for patie

The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls

✍ Brian T. Hill; Lisa Rybicki; Brian J. Bolwell; Stephen Smith; Robert Dean; Matt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB